Association Between Mortality and Detection of Respiratory Viruses in Children During the Peri-Liver Transplant Period
- PMID: 40073386
- DOI: 10.1097/INF.0000000000004795
Association Between Mortality and Detection of Respiratory Viruses in Children During the Peri-Liver Transplant Period
Abstract
Background: To evaluate the disease burden, risk of complications and mortality in children with viral detection during the peri-liver transplant period.
Methods: A retrospective cohort study was conducted between January 2020 and December 2023 at a tertiary university hospital. Children who underwent multiplex polymerase chain reaction testing from 7 days before to 14 days after liver transplantation were included. The primary outcome was the association between peri-transplant viral detection and mortality. Data were obtained from the hospital's medical records and laboratory databases.
Results: A total of 169 children with a median age of 0.9 (interquartile range, 0.5-7.1) years were included. The primary indication for liver transplantation was biliary atresia with liver cirrhosis (47.3%). Living-donor transplantation was performed in 89.9% of cases. Viral detection occurred in 38.5% (65/169) of children, with 57% detected pre-transplant. The most frequently identified viruses were rhinovirus/enterovirus, adenovirus and parainfluenza. Children with viral detection had higher odds of mortality [20% vs. 8.7%; adjusted odds ratio (aOR), 2.56 (95% confidence interval [CI], 1.02-6.42); P = 0.03] and surgical complications [aOR, 2.18 (95% CI, 1.12-4.27); P = 0.02], regardless of the transplant indication or donor type. Bacterial coinfection further increased the odds of mortality in the viral detection group [aOR, 2.64 (95% CI, 1.06-6.61); P = 0.03].
Conclusions: In children with severe hepatocellular dysfunction undergoing liver transplantation, respiratory viral detection during the peri-transplant period was associated with an increased risk of mortality and postoperative surgical complications.
Keywords: children; liver transplantation; mortality; respiratory infection; virus.
Copyright © 2025 Wolters Kluwer Health, Inc. All rights reserved.
Conflict of interest statement
The authors have no funding or conflicts of interest to disclose.
References
-
- Spaeder MC, Carson KA, Vricella LA, et al. Impact of the viral respiratory season on postoperative outcomes in children undergoing cardiac surgery. Pediatr Cardiol. 2011;32:801–806.
-
- Fischer LJ, Castera M, Chin H, et al. Impact of asymptomatic detection of non-SARS-CoV-2 respiratory viruses on pediatric cardiac surgical outcomes. Antimicrob Steward Healthc Epidemiol. 2024;4:e154.
-
- Niermeyer WL, Ball J, Worobetz N, et al. Respiratory viral panels and pediatric airway evaluation: the role of testing for upper respiratory infections to stratify perioperative risk. Int J Pediatr Otorhinolaryngol. 2020;134:110057.
-
- Moynihan K, Barlow A, Alphonso N, et al. Impact of viral respiratory pathogens on outcomes after pediatric cardiac surgery. Pediatr Crit Care Med. 2017;18:219–227.
-
- Li X, Wang X, Li S, et al. Viral respiratory infection, a risk in pediatric cardiac surgery: a propensity-matched analysis. Pediatr Crit Care Med. 2020;21:e431–e440.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
